Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 263 for “"open-label"”.

  1. The Role of Rituals in Open-Label Placebo Effects

    … and well-being even when they are administered openly, without deception. However, research on open-label placebos (OLPs) is limited and there is still some uncertainty regarding how OLP effects can be created consistently. A potential strategy to enhance OLP effects may be the addition of …

    unsw Repository record for The Role of Rituals in Open-Label Placebo Effects (opens in a new tab)

  2. An Open Label Study of the Effects of Levetiracetam in Children with Autism

    This was an open-label study of levetiracetam in children with autism. Many anticonvulsant medications are used for management of externalizing behaviors and mood stability in autism; however, they are not consistently effective and adverse reactions limit their use. The objective of this study was …

    marshall Repository record for An Open Label Study of the Effects of Levetiracetam in Children with Autism (opens in a new tab)

  3. A PILOT STUDY: AN OPEN-LABEL BIOMARKER DEVELOPMENT OF KETAMINE FOR UNIPOLAR REFRACTORY DEPRESSION

    … Fifteen adults diagnosed with TRD completed an open-label study of repeated infusions of low dose ketamine (0.5 mg/kg) over the course of four weeks. Blood was collected from eleven patients at three time points throughout the acute treatment to analyze peripheral biomarkers including irisin, …

    queens Repository record for A PILOT STUDY: AN OPEN-LABEL BIOMARKER DEVELOPMENT OF KETAMINE FOR UNIPOLAR REFRACTORY DEPRESSION (opens in a new tab)

  4. The Use of an Open-Label Placebo to Treat Cancer-Related Fatigue in Cancer Survivors

    … studies indicate that the use of disclosed or open-label placebos reduces self-reported symptoms among patients with irritable bowel syndrome, migraine attacks, and major depression. Methods: The investigator conducted a 7-week pilot study to evaluate the feasibility and effects of an …

    uab Repository record for The Use of an Open-Label Placebo to Treat Cancer-Related Fatigue in Cancer Survivors (opens in a new tab)

  5. Beobachtung der Erfahrungen mit dem Open-Label-Einsatz von Cannabidiol bei Patienten mit pharmakorefraktärer Epilepsie

    … untersucht. <br>Durchgeführt wurde eine Open-Label-Beobachtungsstudie einer dreimonatigen <br>Add-On-Therapie mit synthetischem CBD bei 16 Erwachsenen und 19 Kindern mit einem breitem Spektrum pharmakorefraktärer Epilepsien. Erfasst wurden Anfallsfrequenzen sowie aufgetretene …

    freiburg-diss Repository record for Beobachtung der Erfahrungen mit dem Open-Label-Einsatz von Cannabidiol bei Patienten mit pharmakorefraktärer Epilepsie (opens in a new tab)

  6. Acute Effects of Placebo and Open-Label Placebo Treatments on Muscle Strength, Voluntary Activation, and Neuromuscular Fatigue.

    … on an inert intervention. Interestingly, open-label placebo treatments (i.e., directly telling subjects they are receiving an inactive intervention) have recently shown promise in minimizing pain in clinical patient populations. We utilized a repeated measures design to examine the acute …

    ucf Repository record for Acute Effects of Placebo and Open-Label Placebo Treatments on Muscle Strength, Voluntary Activation, and Neuromuscular Fatigue. (opens in a new tab)

  7. Comparison of adherence to pre-exposure prophylaxis during blinded and open-label phases of a randomized trial

    … during the placebo-controlled and subsequent open-label phases of the study. Learning of PrEP efficacy led to a modest, although statistically significant, increase in adherence: the odds of refilling study medication at each monthly visit increased by 24% (p = 0.03), and the odds of detecting …

    washington Repository record for Comparison of adherence to pre-exposure prophylaxis during blinded and open-label phases of a randomized trial (opens in a new tab)

  8. Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

    … present the 90-day results from the randomised, open-label, parallel-group, investigator-initiated, multinational OVID phase III trial. METHODS: Outpatients aged 50 years or older with acute symptomatic COVID-19 were randomised to receive enoxaparin 40 mg for 14 days once daily vs. standard of …

    zurich Restricted access

  9. An open-label, uncontrolled study to evaluate the effect of verapamil on glycaemic control in type 2 diabetes mellitus patients with hypertension

    Introduction: Type 2 diabetes is a common chronic disease that continues to globally increase in prevalence and is a major healthcare burden. Diabetes and hypertension are frequently coexistent conditions and the use of antihypertensive agents is common in diabetic patients. One antihypertensive …

    strathclyde Repository record for An open-label, uncontrolled study to evaluate the effect of verapamil on glycaemic control in type 2 diabetes mellitus patients with hypertension (opens in a new tab)

  10. Phase 2 randomized open label adaptive platform clinical trial of the clinical and biological effects of IC14 treatment in patients with severe COVID-19

    Background: In I-SPY COVID, a Phase 2 randomized open label adaptive platform clinical trial, we examined the clinical efficacy of the anti-CD14 monoclonal antibody IC14 for patients with severe COVID-19 requiring high-level respiratory support. As detailed in the initial report of the first seven …

    washington Repository record for Phase 2 randomized open label adaptive platform clinical trial of the clinical and biological effects of IC14 treatment in patients with severe COVID-19 (opens in a new tab)

  11. Immunological response to R21/Matrix-M and RH5/Matrix-M malaria vaccine in open-label Phase Ib dose escalation and age de-escalation studies in Africa

    <b>Background:</b> A vaccine can assist with the current malaria elimination efforts. The recently approved sporozoite-based vaccines provide partial protection despite vaccine-induced responses. Factors like previous malaria exposure, age and vaccination regimen could influence vaccine response. …

    the-open-u Download PDF for Immunological response to R21/Matrix-M and RH5/Matrix-M malaria vaccine in open-label Phase Ib dose escalation and age de-escalation studies in Africa (opens in a new tab)

  12. Vitamin D supplementation in patients with Crohn’s Disease and vitamin D deficiency: D-CODE feasibility study. An open label feasibility study for a randomised controlled trial

    … of Gastroenterology IBD section. The survey was open for one month. Survey data was collected using the REDCap online tool. B – An observational, vitamin D screening study was carried out in the gastroenterology and infusion outpatient departments at the Queen Elizabeth Hospital Birmingham …

    birmingham Download PDF for Vitamin D supplementation in patients with Crohn’s Disease and vitamin D deficiency: D-CODE feasibility study. An open label feasibility study for a randomised controlled trial (opens in a new tab)

  13. An open-label study into the efficacy and dosing of probiotic Escherichia coli Nissle 1917 for the prevention of gram-negative gastric colonisation in ventilated intensive care patients

    Twenty-five percent of hospital infections occur in critical care patients. Up to 30% of these develop ventilator associated pneumonia, increasing length of stay, morbidity, mortality and cost. Causative bacteria are predominantly Gram-negative, and with increasing multidrug-resistant strains, we …

    birmingham Download PDF for An open-label study into the efficacy and dosing of probiotic Escherichia coli Nissle 1917 for the prevention of gram-negative gastric colonisation in ventilated intensive care patients (opens in a new tab)

  14. Determining typical doses of injectable diacetylmorphine and hydromorphone for the treatment of opioid use disorder

    … to examine differences in double-blind versus open-label iOAT dose received. The open-label potency ratio between DAM and HDM was calculated and described with percentile ranks. A total of 595,305 injections were registered during the study period among 131 participants. Mean DAM doses ranged …

    ubc Repository record for Determining typical doses of injectable diacetylmorphine and hydromorphone for the treatment of opioid use disorder (opens in a new tab) Download PDF for Determining typical doses of injectable diacetylmorphine and hydromorphone for the treatment of opioid use disorder (opens in a new tab)

Page 1 of 14